Technical Analysis for MLYS - Mineralys Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 14.65 | 3.39% | 0.48 |
MLYS closed up 3.39 percent on Wednesday, May 8, 2024, on 1.87 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
Earnings due: May 9
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 3.39% | |
| Above Upper BB | Strength | 3.39% | |
| Overbought Stochastic | Strength | 3.39% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakout | about 11 hours ago |
| Up 3% | about 11 hours ago |
| Up 2% | about 11 hours ago |
| Possible Pocket Pivot | about 11 hours ago |
| 1.5x Volume Pace | about 17 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of patients with uncontrolled or resistant hypertension. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Hypertension Cardiovascular Disease Treatment Of Hypertension
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Hypertension Cardiovascular Disease Treatment Of Hypertension
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 17.44 |
| 52 Week Low | 5.86 |
| Average Volume | 148,932 |
| 200-Day Moving Average | 10.95 |
| 50-Day Moving Average | 12.98 |
| 20-Day Moving Average | 12.37 |
| 10-Day Moving Average | 12.89 |
| Average True Range | 0.74 |
| RSI (14) | 68.75 |
| ADX | 22.15 |
| +DI | 36.18 |
| -DI | 13.98 |
| Chandelier Exit (Long, 3 ATRs) | 12.66 |
| Chandelier Exit (Short, 3 ATRs) | 12.58 |
| Upper Bollinger Bands | 14.46 |
| Lower Bollinger Band | 10.28 |
| Percent B (%b) | 1.05 |
| BandWidth | 33.76 |
| MACD Line | 0.31 |
| MACD Signal Line | -0.05 |
| MACD Histogram | 0.3552 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 16.29 | ||||
| Resistance 3 (R3) | 16.18 | 15.52 | 16.01 | ||
| Resistance 2 (R2) | 15.52 | 15.11 | 15.58 | 15.92 | |
| Resistance 1 (R1) | 15.09 | 14.85 | 15.31 | 15.20 | 15.83 |
| Pivot Point | 14.43 | 14.43 | 14.54 | 14.49 | 14.43 |
| Support 1 (S1) | 14.00 | 14.02 | 14.22 | 14.11 | 13.47 |
| Support 2 (S2) | 13.34 | 13.76 | 13.40 | 13.38 | |
| Support 3 (S3) | 12.91 | 13.34 | 13.29 | ||
| Support 4 (S4) | 13.02 |
